Aortic root replacement with stentless xenografts in patients with aortic stenosis.


Journal

The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343

Informations de publication

Date de publication:
10 2019
Historique:
received: 22 07 2018
revised: 24 10 2018
accepted: 04 11 2018
pubmed: 13 1 2019
medline: 20 2 2020
entrez: 13 1 2019
Statut: ppublish

Résumé

Stentless bioprosthetic valves such as the Freestyle conduit have been widely used as an option for aortic root replacement in the setting of aortic root aneurysms with acceptable long-term outcomes. However, there is a paucity of data regarding the use of the Freestyle prosthesis in patients with aortic stenosis. All patients with a primary diagnosis of severe aortic stenosis who underwent complete aortic root replacement with Freestyle conduits were included. Primary outcomes included survival and readmissions for heart failure. Secondary outcomes included immediate postoperative complications. In total, 2529 patients with severe aortic stenosis who needed an open aortic valve replacement with a biological prosthesis were operated on between 2011 and 2017. Of these, 294 patients underwent aortic root replacements using the Freestyle conduit with a primary diagnosis of native or prosthetic aortic stenosis. Eighty-four (28.6%) of the patients underwent reoperative sternotomy. The majority (53.7%) of the cohort were men. The mean age was 67.5 ± 13.0 years. Mean Society of Thoracic Surgeons Predicted Risk of Mortality when calculated with the assumption of aortic valve replacement ± coronary artery bypass grafting was 8.10% ± 10.8. The median follow-up time for the entire group was 2.7 years (interquartile range 0.9-4.5 years). Operative (30-day) mortality was 7.1% (n = 21). Kaplan-Meier mortality estimates at 1 and 5 years are 16.6% and 27.6%, respectively. Mean gradients were 7.15 ± 4.47 mm Hg at 1 month and 6.32 ± 4.76 mm Hg at 1 year. Readmissions for heart failure at 30 days, 1 year, and 5 years were 5.6%, 11.8%, and 17.4%, respectively. Aortic root replacement using Freestyle bioprostheses is a viable option for patients with severe aortic stenosis with low risk of hospital readmission for heart failure.

Identifiants

pubmed: 30635191
pii: S0022-5223(18)33125-8
doi: 10.1016/j.jtcvs.2018.11.028
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1021-1027

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2018 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Valentino Bianco (V)

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh.

Arman Kilic (A)

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh; Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pa.

Thomas G Gleason (TG)

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh; Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pa.

Edgar Aranda-Michel (E)

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh.

Forozan Navid (F)

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh; Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pa.

Suresh Mulukutla (S)

Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pa.

Ibrahim Sultan (I)

Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh; Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pa. Electronic address: sultani@upmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH